These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 510343)

  • 1. Augmentation of vincristine-induced thrombocytosis by norethisterone.
    Cantwell BM; Begent RH; Rubens RD
    Eur J Cancer (1965); 1979 Aug; 15(8):1065-9. PubMed ID: 510343
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombocytosis in quiescent chronic granulocytic leukaemia after vincristine and 6-mercaptopurine therapy.
    Feliu E; Cervantes F; Blade J; Rozman C
    Acta Haematol; 1980; 64(4):224-6. PubMed ID: 6781203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisolone.
    Russell JA; Baker JW; Dady PJ; Ford HT; Gazet JC; McKinna JA; Nash AG; Powles TJ
    Cancer; 1978 Feb; 41(2):396-9. PubMed ID: 630530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

  • 5. Vincristine induced thrombocytosis.
    Malhotra OP; Mohan A
    J Assoc Physicians India; 1994 Mar; 42(3):258. PubMed ID: 7860525
    [No Abstract]   [Full Text] [Related]  

  • 6. Norethisterone acetate as secondary endocrine treatment in advanced breast cancer.
    da Luz RJ; Rubens RD
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1879-80. PubMed ID: 2632269
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Macrae KD
    Br J Cancer; 1973 Nov; 28(5):459-61. PubMed ID: 4758373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progestogens in the treatment of advanced breast cancer. Clinical study of norethisterone acetate].
    Clavel B; Bourdin JS
    Sem Hop; 1970 Jan; 46(3):170-88. PubMed ID: 4313239
    [No Abstract]   [Full Text] [Related]  

  • 10. The polychemotherapeutic treatment of advanced breast cancer.
    Brown I; Arthur K; Banks AJ; Bond WH; Chowdhury MS; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ward HW
    Clin Oncol; 1977 Jun; 3(2):183-9. PubMed ID: 872472
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
    Eagan RT; Ahmann DL; Bisel HF
    Oncology; 1976; 33(3):146-8. PubMed ID: 1012648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the combination of adriamycin and cyclophosphamide (alone or with other agents) for the treatment of breast cancer.
    Salmon SE; Jones SE
    Oncology; 1979; 36(1):40-7. PubMed ID: 156337
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma.
    Brambilla C; De Lena M; Bonadonna G
    Cancer Chemother Rep; 1974; 58(2):251-3. PubMed ID: 4598244
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy for thrombocytopenia with bone marrow metastases from breast cancer.
    Dady PJ; Gazet JC; Ford HT; Powles TJ
    Br Med J; 1977 Feb; 1(6060):554. PubMed ID: 843805
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy with adriamycin, cyclophosphamide and vicristine for advanced breast cancer supplemented with non cross-resistant combination.
    Jain SP; Pandey UC; Tandon US; Jain KK; Agarwal S
    Indian J Cancer; 1979; 16(3-4):43-6. PubMed ID: 540959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience in the treatment of metastatic breast carcinoma with norethisterone acetate in a clinical study].
    Stier G; Gürtler R; Schmidt UM
    Arch Geschwulstforsch; 1989; 59(2):93-8. PubMed ID: 2655553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polychemotherapeutic treatment of patients with metastatic breast cancer.
    Balázs M; Tüske M
    Acta Med Hung; 1986; 43(4):407-11. PubMed ID: 3601586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cytotoxic and progestogen therapy for advanced breast cancer.
    Rubens RD; Begent RH; Knight RK; Sexton SA; Hayward JL
    Cancer; 1978 Oct; 42(4):1680-6. PubMed ID: 361207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin, vincristine, and cis-diamminedichloroplatinum (II) therapy in patients with advanced breast cancer.
    Trump DL; Ettinger DS; Abeloff MD
    Med Pediatr Oncol; 1981; 9(1):1-3. PubMed ID: 7007853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.